Kimberly Redmond | |

At least 25 states, plus Washington, DC, have now fully vaccinated at least half of their adult residents against COVID-19, according to new data from the US Centers for Disease Control and Prevention (CDC).

Those states are Alaska, California, Colorado, Connecticut, Delaware, Hawaii, Iowa, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nebraska, New Hampshire, New Jersey, New Mexico, New York, Oregon, Pennsylvania, Rhode Island, South Dakota, Vermont, Virginia, Washington and Wisconsin.

Reuters | |

Uber Technologies Inc and rival Lyft Inc on Monday launched COVID-19 vaccine ride programs in partnership with the White House, offering Americans free rides or discounts for their trips to and from a vaccination site.

Customers who have booked a vaccine appointment can request a ride through the Uber app and either incur no charges if the trip costs less than $25, or receive a $25 discount for their journey, the company said.

AP News | |

A steady crowd of people flowed into the New England Patriots’ stadium for their second dose of the COVID-19 vaccine this week in Massachusetts, which is nearing its goal of vaccinating more than 4 million and plans to close its biggest clinics in little more than a month.

In the Deep South, meanwhile, one of the largest clinics in Alabama shut down Wednesday and others will follow in the coming weeks because demand for the shot has plunged.

Kimberly Redmond | |

Frontline essential workers across the US are criticizing the US Centers for Disease Control and Prevention’s (CDC) announcement last week that individuals fully vaccinated against COVID-19 no longer need to wear masks indoors and outdoors.

In a statement released Saturday, National Nurses United (NNU), the country’s largest union of registered nurses, said the CDC’s latest guidance “is not based on science, does not protect public health and threatens the lives of patients, nurses and other frontline workers across the country.”

Kimberly Redmond | |

Concern about contracting COVID-19 are at the lowest level in a year, according to a new poll by Gallup.

In poll released Thursday showed that just 30% of Americans are worried about becoming infected with the virus, the lowest figure since Gallup began tracking public sentiment regarding the pandemic in April 2020.

Kimberly Redmond | |

The US Centers for Disease Control and Prevention (CDC) announced Thursday that fully vaccinated adults can safely resume activities indoors and outdoors without wearing face masks or practicing social distancing in gatherings. 

According to the CDC, people vaccinated against COVID-19 now only need to wear face masks under certain circumstances, such as in healthcare settings, on public transportation or in areas where local or state governments mandate it.  They wil...

Kimberly Redmond | |

For the first time in two months, new COVID-19 cases declined significantly in Europe, but infection rates remain high, according to the World Health Organization (WHO).

Despite the downward trend, WHO regional director for Europe, Dr. Hans Kluge, warned Thursday that the threat posed by coronavirus “remains present.”

Kimberly Redmond | |

BioNTech SE (Nasdaq: BNTX) is seeking more details following reports from Israel of heart inflammation cases among people who received the COVID-19 vaccine developed by the German startup and Pfizer Inc (NYSE: PFE).

On Wednesday, BioNTech’s chief executive officer Ugur Sahin said the cases appeared to be anecdotal and that monitoring by public health officials in countries including the US and Germany showed no unusual side effects or similar symptoms.

Kimberly Redmond | |

Top White House officials blasted comedian and podcast host Joe Rogan on Wednesday after he advised his younger listeners against getting the COVID-19 vaccine.

During an appearance on NBC’s “The Today Show,” Dr. Anthony Fauci, the nation’s top infectious disease expert and President Joe Biden’s chief medical adviser, called Rogan’s comments “incorrect” and explained why he takes issue with the remarks made.

Kimberly Redmond | |

Pfizer Inc’s (NYSE: PFE) experimental oral drug to treat COVID-19 could be available by the end of 2021, according to the pharmaceutical company’s chairman and chief executive officer Albert Bourla.

The drug, for which Pfizer began early-stage clinical trials in March, belongs to a class of medicines called protease inhibitors, similar to treatments used for other viral pathogens, like HIV and hepatitis C, CNBC reported.